ELISTAIR
8.6.2020 19:33:06 CEST | Business Wire | Press release
Elistair has announced the release of the Safe-T 2, their most advanced and powerful tethering system for use with commercially available drones. Key Features include IP54 rating, up to 125m / 400 feet micro-tether, 2 200 watts max continuous power, fiber optics option, and industry leading weight/power ratio from its patented Dynamic Voltage Optimization (DVO). The Safe-T 2 provides users with unmatched power efficiency and enables safe persistent flight time for UAVs .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005629/en/
SAFE-T 2 Video: https://youtu.be/9hBA41eDXHM
Since the launch of its first tethering station in 2015, Elistair has quickly become the industry leader in tethered drone systems with over 600 stations deployed to help security forces monitor events, secure sites, protect assets. The Safe-T 2 which has been built on the success of the Safe-T product line, deployed in over 60 countries by governmental organisations, industrial groups, and security forces will take tethering operations to a new level.
“To design the Safe-T 2, we worked in close collaboration with users who challenged us with their critical feedback. We rethought the entire solution to build the perfect tethering system for security operations.” Said Timothée PENET, Elistair Co-founder and CTO. “With up to 2,2 kW max continuous power and 2,8 kW peak power, it allows for higher flights with heavier payloads, thus enabling security forces to cover larger areas with a single system.”
Smart and Secured
The secure Dual-Comms option (Fiber optic and BPL), offers a redundant tethered data link or the possibility to select the best suited technology for the aircraft or payload. A patented Brake system allows the user to adapt the maximal tether length, depending on the safety zone needed, for instance in urban or crowded environments. Like its predecessor, the Safe-T 2 integrates Elistair’s live flight management system with T-monitor application offering optimal flight control for safer operations.
Ready for integration
Engineered to meet the most demanding missions with its rugged weather-resistant design, and compact modular metallic structure, the Safe-T 2 offers mounting plates and optional software development kit (SDK) for seamless integration into vehicles and fixed structures whilst also being agile enough for a single operator to deploy. Its interchangeable micro-tethers and smart adaptive winch control laws allow the operator to reconfigure the station and use the best tether weight/power range for each drone.
More information: www.elistair.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200608005629/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom